Literature DB >> 26720286

Germline Sequence Variants and Ovarian Cancer: Known-Knowns and Known-Unknowns.

Elena M Stoffel1, Eric R Fearon2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26720286     DOI: 10.1001/jamaoncol.2015.5622

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

2.  Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.

Authors:  Judith Balmaña; Laura Digiovanni; Pragna Gaddam; Michael F Walsh; Vijai Joseph; Zsofia K Stadler; Katherine L Nathanson; Judy E Garber; Fergus J Couch; Kenneth Offit; Mark E Robson; Susan M Domchek
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.